cardiac ectopic fat deposits
Showing 1 - 25 of >10,000
Type 2 Diabetes Trial in Marseille (Empagliflozin 10Mg Tab)
Completed
- Type 2 Diabetes
- Empagliflozin 10Mg Tab
-
Marseille, FranceAssistance Publique Hopitaux de Marseille
Feb 13, 2020
Cardiovascular Diseases, Obesity, Visceral, Liver Fat Trial in Québec (High-volume road cycling)
Completed
- Cardiovascular Diseases
- +4 more
- High-volume road cycling
-
Québec, CanadaInstitut universitaire de cardiologie et de pneumologie de Québe
May 30, 2023
Coronary Artery Disease, Carotid Artery Diseases, Atherosclerosis Trial in United States (Atorvastatin, Niacin, Colesevelam)
Completed
- Coronary Artery Disease
- +2 more
- Atorvastatin
- +4 more
-
Los Angeles, California
- +3 more
May 16, 2022
Diabetes, PreDiabetes, Diet Habit Trial (CURE-DM)
Not yet recruiting
- Diabetes Mellitus
- +2 more
- CURE-DM
- (no location specified)
Jun 22, 2023
Growth Hormone Dynamics and Cardiac Steatosis in HIV
Completed
- Human Immunodeficiency Virus
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Jul 18, 2022
Reversal of Obese/Diabetic Cardiomyopathy After Gastric Bypass
Active, not recruiting
- Cardiomyopathy
-
Saint Louis, MissouriWashington University School of Medicine
Jan 30, 2023
Cardiac Amyloidosis Screening at Trigger Finger Release
Completed
- Amyloidosis
- +3 more
- Biopsy
-
Cleveland, OhioCleveland Clinic
Dec 21, 2021
Lumbar Spine Stenosis Specimens for Identification of
Not yet recruiting
- Lumbar Spinal Stenosis
- +5 more
- Tc99-PYP or Tc99-HDMP Scan
-
Beverly Hills, California
- +5 more
Sep 12, 2023
Systemic Amyloidosis Trial in Knoxville (99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.,
Recruiting
- Systemic Amyloidosis
- 99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.
- 99mTc-Pyrophosphate and 99mtc-p5+14 - an Amyloid Reactive Peptide Labeled With Technetium-99m.
-
Knoxville, TennesseeUniversity of Tennessee Graduate School of Medicine
Jul 10, 2023
Chronic Kidney Diseases Trial in Nashville (dulaglutide injection)
Recruiting
- Chronic Kidney Diseases
- dulaglutide injection
-
Nashville, TennesseeVanderbilt University Medical Center
Mar 20, 2022
NAFLD Trial (Caloric restriction intervention, No intervention)
Not yet recruiting
- NAFLD
- Caloric restriction intervention
- No intervention
- (no location specified)
Apr 24, 2023
Heart Disease, Aging, Amyloidosis Trial in France (a basal LV septum biopsy)
Active, not recruiting
- Heart Disease
- +3 more
- a basal LV septum biopsy
-
Creteil, France
- +5 more
Sep 30, 2022
Liver Fat, Cardiac Function, Lipid Disorder Trial in Oxford (Diet)
Recruiting
- Liver Fat
- +3 more
- Diet
-
Oxford, United KingdomOxford Centre for Diabetes, Endocrinology and Metabolism
Jul 18, 2023
Obesity, Adolescent Obesity Trial in Clermont-Ferrand (3-month lifestyle intervention)
Unknown status
- Obesity
- Adolescent Obesity
- 3-month lifestyle intervention
-
Clermont-Ferrand, FranceCHU de Clermont-Ferrand
Mar 13, 2020
Iron Deposits in Pancreas by MRI Method of Dialysis
Not yet recruiting
- Iron Deposition
- +2 more
- MRI
-
Quincy-sous-Sénart, FranceHôpital Privé Claude Galien
Oct 20, 2022
Amyloidosis, Primary, Cardiomyopathy Trial in Boston (F-18 florbetapir/C-11 acetate PET, MRI, N-13 ammonia PET)
Recruiting
- Amyloidosis, Primary
- Cardiomyopathy
- F-18 florbetapir/C-11 acetate PET
- +2 more
-
Boston, MassachusettsBrigham and Womens' Hospital
Oct 23, 2022
Screening for Systemic Amyloidosis Via the Ligamentum Flavum
Completed
- Amyloid
- +4 more
- Biopsy
-
Cleveland, OhioCleveland Clinic
Dec 21, 2021
Cardiovascular Diseases, Cardiovascular Morbidity, Metabolic Disease Trial (Time restricted eating, nutrition education, and
Not yet recruiting
- Cardiovascular Diseases
- +2 more
- Time restricted eating, nutrition education, and sedentary time reduction strategies
- (no location specified)
Jun 21, 2022
Mitochondrial Function in Transthyretin Amyloidosis
Recruiting
- Cardiac Amyloidosis
-
Fort-de-France, MartiniqueCHU de Martinique
Jul 7, 2021
Non-Alcoholic Fatty Liver Disease Trial in Tanta (Cholecalciferol, Placebo)
Recruiting
- Non-Alcoholic Fatty Liver Disease
- Cholecalciferol
- Placebo
-
Tanta, EgyptTanta Unuversity
Oct 30, 2022
Molecular Markes of Fibrosis of Endometriosis and Their Use in
Recruiting
- Molecular Markers of Fibrosis of Single Types of Endometriosis and Their Use in Predicting Disease Severity
- Molecular markes of fibrosis of single types of endometriosis and their use in predicting disease severity
-
Prague, CzechiaGeneral University Hospital in Prague
Aug 28, 2023
Millenials, Risk for Metabolic Syndrome Trial in Nashville (High Carbohydrate or Tree Nut Food Snacks)
Recruiting
- Millenials
- Risk for Metabolic Syndrome
- High Carbohydrate or Tree Nut Food Snacks
-
Nashville, TennesseeVanderbilt University Medical Center
Oct 21, 2022
Ectopic Pregnancy Trial (single-port laparoscopy)
Not yet recruiting
- Ectopic Pregnancy
- single-port laparoscopy
- (no location specified)
Jun 5, 2023
Peripheral Arterial Disease in People With Cancer Who Will Be
Recruiting
- Peripheral Arterial Disease (PAD) in Cancer Patients
- ABI/TBI
- Questionnaires
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Feb 22, 2023
Polycystic Ovary Syndrome, Non-Alcoholic Fatty Liver Disease, Metabolic Syndrome Trial in New York (Metformin, Placebo)
Active, not recruiting
- Polycystic Ovary Syndrome
- +2 more
- Metformin
- Placebo
-
New York, New YorkColumbia University Medical Center
Jul 19, 2022